Author Manuscript Published OnlineFirst on May 31, 2019; DOI: 10.1158/1541-7786.MCR-18-1204 Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited. Gamma-glutamyltransferase 1 promotes clear cell renal cell carcinoma initiation and progression Ankita Bansal1, Danielle J. Sanchez1,2, Vivek Nimgaonkar1, David Sanchez1, Romain Riscal1, Nicolas Skuli1, M. Celeste Simon1,2* 1Abramson Family Cancer Research Institute, 456 BRB II/III, 421 Curie Boulevard, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA 19104-6160, USA 2Department of Cell and Developmental Biology, 456 BRB II/III, 421 Curie Boulevard, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA 19104-6160, USA Running Title: GGT1 in clear cell renal cell carcinoma * Corresponding Author: Dr. M. Celeste Simon, Ph.D. Abramson Family Cancer Research Institute, 456 BRB II/III, 421 Curie Boulevard, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA 19104-6160, USA, Email:
[email protected] Phone: 215-746-5532 Keywords: cancer metabolism, kidney cancer, glutathione, GGT1, chemotherapy Financial Support: This work was supported by NIH grant P01CA104838 to M.C.S. Conflicts of Interest Statement: The authors declare that no conflict of interest exists. Word Count: 4872 (excluding references and figure legends) Figures: 6 primary figures, 6 supplemental figures 1 Downloaded from mcr.aacrjournals.org on September 25, 2021. © 2019 American Association for Cancer Research. Author Manuscript Published OnlineFirst on May 31, 2019; DOI: 10.1158/1541-7786.MCR-18-1204 Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited.